Norden Group’s Novo Nordisk NVO Stock Holding History

Norden Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86M	Sell	38,789 -3,863	-9%	-$166K	0.15%	122
2026 Q1	$1.57M	Buy	42,652 +19,651	+85%	+$931K	0.15%	128
2025 Q4	$1.17M	Sell	23,001 -10,398	-31%	-$532K	0.11%	164
2025 Q3	$1.85M	Sell	33,399 -62,933	-65%	-$3.68M	0.19%	110
2025 Q2	$6.65M	Buy	96,332 +65,877	+216%	+$4.48M	0.72%	23
2025 Q1	$2.11M	Sell	30,455 -9,866	-24%	-$815K	0.24%	83
2024 Q4	$3.47M	Sell	40,321 -5,380	-12%	-$582K	0.39%	58
2024 Q3	$5.44M	Sell	45,701 -6,071	-12%	-$810K	0.64%	33
2024 Q2	$7.39M	Buy	51,772 +21,867	+73%	+$2.9M	1.49%	10
2024 Q1	$3.84M	Buy	29,905 +4,128	+16%	+$491K	0.78%	30
2023 Q4	$2.67M	Sell	25,777 -3,681	-12%	-$364K	0.46%	20
2023 Q3	$2.68M	Buy	+29,458	New	+$2.59M	0.88%	22

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norden Group's NVO Position: Q2 2026 in Review

Norden Group reduced its Novo Nordisk (NVO) stake by 9.1% in Q2 2026, selling an estimated $166K and leaving 38,789 shares worth $1.86M. The position accounts for 0.15% of the portfolio, ranked #122.

Norden Group first reported a position in NVO in Q3 2023 and has held it in 12 quarters since. The position peaked at $7.39M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Norden Group held 38,789 shares of Novo Nordisk worth $1.86M as of Q2 2026.
Norden Group sold 3,863 Novo Nordisk shares in Q2 2026, an estimated $166K.
Novo Nordisk made up 0.15% of Norden Group's portfolio in Q2 2026, its #122 holding.
Norden Group first reported a position in Novo Nordisk in Q3 2023 and has held it in 12 quarters since.
Norden Group's Novo Nordisk position peaked at $7.39M in Q2 2024.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.